To provide treatment recommendations for Juvenile Idiopathic Arthritis associated Uveitis : a Seven Years' Single-Centre Experience
Latest Information Update: 25 Jun 2021
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Ciclosporin (Primary) ; Cyclophosphamide (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Methotrexate (Primary) ; Tocilizumab (Primary) ; Nonsteroidal anti-inflammatories
- Indications Juvenile rheumatoid arthritis; Uveitis
- Focus Therapeutic Use
- 25 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism